Literature DB >> 3098860

Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.

J Grøndahl-Hansen, E Ralfkiaer, L S Nielsen, P Kristensen, G Frentz, K Danø.   

Abstract

Biopsies of involved and uninvolved skin from psoriatic patients and of normal skin were stained immunocytochemically with monoclonal antibodies against urokinase-type (u-PA) and tissue-type (t-PA) plasminogen activator using a multilayer peroxidase technique. Epidermis from psoriatic lesions showed focal staining for u-PA in and between the basal keratinocytes in the suprapapillary epidermal areas, while t-PA was found in the superficial keratinizing cells, including both stratum spinosum and the parakeratotic layer. No staining of keratinocytes was observed in uninvolved and normal skin. The specificity of the staining was supported by the finding that 3 different monoclonal antibodies and polyclonal antibodies against each of the plasminogen activators gave identical staining, while monoclonal antibodies of irrelevant specificity gave no staining. The present findings suggest abnormalities in the regulation of both types of plasminogen activators in psoriatic epidermis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098860     DOI: 10.1111/1523-1747.ep12464827

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Inhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library.

Authors:  Jan K Jensen; Anders Malmendal; Birgit Schiøtt; Sune Skeldal; Katrine E Pedersen; Leyla Celik; Niels Chr Nielsen; Peter A Andreasen; Troels Wind
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

2.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

3.  Easy and reliable double-immunogold labelling of herpes simplex virus type-1 infected cells using primary monoclonal antibodies and studied by cryosection electron microscopy.

Authors:  H L Jensen; B Norrild
Journal:  Histochem J       Date:  1999-08

4.  Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Authors:  J M Rox; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

5.  Differential expression of SKALP/Elafin in human epidermal tumors.

Authors:  H A Alkemade; H O Molhuizen; I M van Vlijmen-Willems; U J van Haelst; J Schalkwijk
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

6.  Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis.

Authors:  B Lyons-Giordano; D Loskutoff; C S Chen; G Lazarus; M Keeton; P J Jensen
Journal:  Histochemistry       Date:  1994-02

7.  Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.

Authors:  Kenneth A Botkjaer; Elena I Deryugina; Daniel M Dupont; Henrik Gårdsvoll; Erin M Bekes; Cathrine K Thuesen; Zhuo Chen; Zhou Chen; Michael Ploug; James P Quigley; Peter A Andreasen
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

8.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.

Authors:  W Glinski; M Pierozynska-Dubowska; M Glinska-Ferenz; S Jablońska
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples.

Authors:  K Kuwae; K Matsumoto-Miyai; S Yoshida; T Sadayama; K Yoshikawa; K Hosokawa; S Shiosaka
Journal:  Mol Pathol       Date:  2002-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.